搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
New Atlas
3 小时
Popular sleeping pill shown to block brain's critical cleaning cycle
Each night, our brains execute a "wash and rinse" routine that clears away harmful protein waste linked to neurodegenerative ...
BioPharma Dive
2 天
J&J to buy psychiatric drug developer Intra-Cellular for $14.6B
Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar ...
healthday on MSN
1 天
What Do Sleep Medications Do to Your Brain?
The sleep aid Ambien could be allowing toxic proteins to pollute the brain, potentially increasing a person’s risk of ...
1 天
Revolutionizing Biotech: How NeOnc Technologies Is Striving To Transform Brain Cancer ...
Dr. Chen is developing a new delivery system which is designed to help cancer drugs cross the blood-brain barrier.
NOLA.com
1 天
Can weight loss drugs curb alcohol addictions? New research looks at the possibility.
Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.
5 天
on MSN
5 best supplements to support your mental health, according to a psychiatrist
The supplement's two main ingredients, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), help promote healthy blood ...
4 天
Alzheimer’s drugs eyed as next big obesity-like opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Medicine Buffalo
3 小时
Pros and cons of popular weight-loss drugs
Pharmacy professor Nicole Albanese discusses the science behind drugs like Ozempic and Wegovy, their potential to treat other ...
5 天
on MSN
Alzheimer’s Drugs Eyed by Investors Seeking Obesity-Like Gains
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
1 天
on MSN
J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal
Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈